Intracavitary Yttrium-90 Colloid Therapy for Cystic Sellar Masses: A Phase II Clinical Trial With 5-Year Follow-Up
Stereotactic treatment of CSMs with intracavitary 90 Y is associated with sustained reduction in tumor-cyst volume, improved visual function, and stable endocrine function at 5-year follow-up.
Authors
- Steven Burrell
- Ryan Greene (ORCID: https://orcid.org/0000-0002-8211-7450)
- Mark A. MacLean (ORCID: https://orcid.org/0000-0002-8535-0776)
- David B. Clarke (ORCID: https://orcid.org/0000-0003-3816-6674)
- Syed Ali Imran (ORCID: https://orcid.org/0000-0001-5066-871X)
- Syed Ameen Ahmad (ORCID: https://orcid.org/0000-0002-6179-5252)
- Andrea L.O. Hebb
- Anas Tahir
Institutions
- Dalhousie University (CA)
Publication Details
- Journal
- Neurosurgery
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1227/neu.0000000000003460
- Citations
- 1
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.29